Document Type : Original Research

Authors

1 Department of Internal Medicine, Clinical Research Development Unit, Hajar Hospital, Shahrekord University of Medical Sciences, Shahrekord, Iran

2 Department of Parasitology, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran

3 Evidence Based Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

4 Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, USA.

5 Department of Infectious Disease, Clinical Research Development Unit, Hajar Hospital, Shahrekord University of Medical Sciences, Shahrekord, Iran

6 Department of Epidemiology and Biostatistics, School of Health, Modeling in Health Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran

7 Clinical and Anatomical Pathologist, Clinical Research Development Unit, Shahrekord University of Medical Sciences, Shahrekord, Iran

10.30699/ijp.2020.130491.2442

Abstract

Background & Objective: 
Previous studies have addressed the electrolyte abnormalitiessuch as hypocalcemiain COVID-19 patients. We aimed to compare the laboratory findings especially the electrolyte levels amongCOVID-19 patients and healthy controls and evaluate their prognostic values.
Materials and Methods: This case-control study included 91 COVID-19 patients and 169 healthy individuals. Their laboratory parameters including electrolytes, albumin, liver enzymes, complete blood count, vitamin D, and parathyroid hormone (PTH) were compared. We also analyzed the association between these markers and the major outcomes including severity, mortality and hospitalization.
Results: Among patients with COVID-19, 59.3% of the patients had hypocalcemia on admission while in control group only 32.5% had low calcium level (OR=3.02, 95% CI: 1.79-5.13, p <0.001). The rates of death and ICU admission were significantly higher among the patients in hypocalcemic group than those of eucalcemic group (85.7% vs 14.3% and 33.3% Vs 9.1%, respectively). However, there was no significant difference in the mean PTH and vitamin D levels between the two groups. In terms of the severity of the infection, 74.1% of patients in hypocalcemic group had a severe infection while 24.3% of the patients in eucalcemic group were diagnosed with severe infection (OR=8.89, 95% CI: 3.38-23.37, p <0.001).
Conclusion: Patients with COVID-19 had considerable laboratory abnormalities including hypocalcemia. The hypocalcemia was also associated with worse major clinical outcomes and higher mortality risk.

Keywords

Main Subjects

Lippi G, South AM, Henry BM. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). AnnClinBiochem. 2020;57(3):262-5. [DOI:10.1177/0004563220922255] [PMID]

World Health Organization. Report of the WHO-China Joint Mission on coronavirus disease 2019 (COVID-19). 2020. World Health Organization: Geneva, Switzerland. Available at https://www.who.int/docs/default-source/coronaviruse/who-china-jointmission-on-covid-19-final-report. pdf. Accessed. 2020 Mar;6.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P. A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine. 2020 Jan 24. [DOI:10.1056/NEJMoa2001017] [PMID] [PMCID]

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.Jama. 2020;323(11):1061-9. [DOI:10.1001/jama.2020.1585] [PMID] [PMCID]

Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, Li SB, Wang HY, Zhang S, Gao HN, Sheng JF. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. Bmj. 2020;368. [DOI:10.1136/bmj.m606] [PMID] [PMCID]

Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al.Clinical characteristics of coronavirus disease 2019 in China. N Engl JMed. 2020;382(18):1708-20. [DOI:10.1056/NEJMoa2002032] [PMID] [PMCID]

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020;395(10223):497-506. [DOI:10.1016/S0140-6736(20)30183-5]

MacLaren G, Fisher D, Brodie D. Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation. Jama. 2020;323(13):1245-6. [DOI:10.1001/jama.2020.2342] [PMID]

World Health Organization. Report of the WHO-China joint mission on Coronavirus Disease 2019 (COVID-19). February 28, 2020.

Lipsitch M, Swerdlow DL, Finelli L. Defining the epidemiology of Covid-19-studies needed. N Engl JMed. 2020;382(13):1194-6. [DOI:10.1056/NEJMp2002125] [PMID]

Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. Jama. 2003;289(21):2801-9. [DOI:10.1001/jama.289.21.JOC30885] [PMID]

Uyeki TM, Mehta AK, Davey Jr RT, Liddell AM, Wolf T, Vetter P, et al. Clinical management of Ebola virus disease in the United States and Europe. N Engl J Med. 2016;374(7):636-46. [DOI:10.1056/NEJMoa1504874] [PMID] [PMCID]

Sun JK, Zhang WH, Zou L, Liu Y, Li JJ, Kan XH, Dai L, Shi QK, Yuan ST, Yu WK, Xu HY. Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019. Aging (Albany NY). 2020;12(12):11287. [DOI:10.18632/aging.103526] [PMID] [PMCID]

Cao M, Zhang D, Wang Y, Lu Y, Zhu X, Li Y, et al.Clinical features of patients infected with the 2019 novel coronavirus (COVID-19) in Shanghai, China. MedRxiv. 2020. [DOI:10.1101/2020.03.04.20030395]

Bossoni S, Chiesa L, Giustina A. Severe hypocalcemia in a thyroidectomized woman with Covid-19 infection. Endocrine. 2020:1. [DOI:10.1007/s12020-020-02326-0] [PMID] [PMCID]

Nair P, Lee P, Reynolds C, Nguyen ND, Myburgh J, Eisman JA, et al. Significant perturbation of Vitamin D-parathyroid-calcium axis and adverse clinical outcomes in critically ill patients. Intensive Care Med. 2013;39(2):267-74. [DOI:10.1007/s00134-012-2713-y] [PMID]

Forsythe RM, Wessel CB, Billiar TR, Angus DC, Rosengart MR. Parenteral calcium for intensive care unit patients. Cochrane Database of Systematic Reviews. 2008 (4). [DOI:10.1002/14651858.CD006163.pub2] [PMID]

Zhang Z, Chen K, Ni H. Calcium supplementation improves clinical outcome in intensive care unit patients: a propensity score matched analysis of a large clinical database MIMIC-II. SpringerPlus. 2015;4(1):594. [DOI:10.1186/s40064-015-1387-7] [PMID] [PMCID]

Lipsitch M, Swerdlow DL, Finelli L. Defining the epidemiology of Covid-19-studies needed. N Engl J Med.2020;382(13):1194-6. [DOI:10.1056/NEJMp2002125] [PMID]

Yang Z, Liu J, Zhou Y, Zhao X, Zhao Q, Liu J. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis. J Infect. 2020. [DOI:10.1016/j.jinf.2020.03.062] [PMID] [PMCID]

Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet. 2020;395(10229):1033-4. [DOI:10.1016/S0140-6736(20)30628-0]

Hendy GN, Canaff L. Calcium-sensing receptor, proinflammatory cytokines and calcium homeostasis. InSeminars in cell & developmental biology 2016 Jan 1 (Vol. 49, pp. 37-43). Academic Press. [DOI:10.1016/j.semcdb.2015.11.006] [PMID]

Caldwell Jr FT, Graves DB, Wallace BH. Pathogenesis of fever in a rat burn model: the role of cytokines and lipopolysaccharide. J Burn Care Rehabil. 1997;18(6):525-30. [DOI:10.1097/00004630-199711000-00010] [PMID]

Kowal-Vern A, Walenga JM, Hoppensteadt D, Sharp-Pucci M, Gamelli RL. Interleukin-2 and interleukin-6 in relation to burn wound size in the acute phase of thermal injury. J Am Coll Surg. 1994;178(4):357-62.

Klein GL, Herndon DN, Goodman WG, Langman CB, Phillips WA, Dickson IR, Eastell R, Naylor KE, Maloney NA, Desai M, Benjamin D. Histomorphometric and biochemical characterization of bone following acute severe burns in children. Bone. 1995;17(5):455-60. [DOI:10.1016/8756-3282(95)00279-1]

Li X, Hu C, Su F, Dai J. Hypokalemia and clinical implications in patients with coronavirus disease 2019 (COVID-19). MedRxiv. 2020 Jan 1.